ES2787882T3 - Un dispositivo intravaginal, y un método para reducir la velocidad de difusión de ingredientes activos en dicho dispositivo intravaginal - Google Patents

Un dispositivo intravaginal, y un método para reducir la velocidad de difusión de ingredientes activos en dicho dispositivo intravaginal Download PDF

Info

Publication number
ES2787882T3
ES2787882T3 ES14705219T ES14705219T ES2787882T3 ES 2787882 T3 ES2787882 T3 ES 2787882T3 ES 14705219 T ES14705219 T ES 14705219T ES 14705219 T ES14705219 T ES 14705219T ES 2787882 T3 ES2787882 T3 ES 2787882T3
Authority
ES
Spain
Prior art keywords
layer
intravaginal ring
active ingredient
particulate material
polymeric material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES14705219T
Other languages
English (en)
Spanish (es)
Inventor
John Ingvar Feldtblad Kendrup
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sever Pharma Solutions AB
Original Assignee
QPharma AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QPharma AB filed Critical QPharma AB
Application granted granted Critical
Publication of ES2787882T3 publication Critical patent/ES2787882T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
    • A61F6/142—Wirelike structures, e.g. loops, rings, spirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
ES14705219T 2013-02-08 2014-01-31 Un dispositivo intravaginal, y un método para reducir la velocidad de difusión de ingredientes activos en dicho dispositivo intravaginal Active ES2787882T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1350155 2013-02-08
PCT/IB2014/058696 WO2014122563A1 (en) 2013-02-08 2014-01-31 An intra vaginal device, and a method of reducing the rate of diffusion of active ingredients in said intra vaginal device

Publications (1)

Publication Number Publication Date
ES2787882T3 true ES2787882T3 (es) 2020-10-19

Family

ID=50115933

Family Applications (1)

Application Number Title Priority Date Filing Date
ES14705219T Active ES2787882T3 (es) 2013-02-08 2014-01-31 Un dispositivo intravaginal, y un método para reducir la velocidad de difusión de ingredientes activos en dicho dispositivo intravaginal

Country Status (6)

Country Link
US (2) US9775905B2 (enExample)
EP (1) EP2953595B1 (enExample)
JP (1) JP2016508789A (enExample)
ES (1) ES2787882T3 (enExample)
HU (1) HUE049219T2 (enExample)
WO (1) WO2014122563A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE539540C2 (sv) 2013-09-12 2017-10-10 Qpharma Ab Ett läkemedelsavgivningssystem för en eller flera aktiva beståndsdelar
CN108135910B (zh) * 2015-05-13 2022-12-02 拜耳股份有限公司 长效药物递送装置及其在避孕中的用途
CN108392310A (zh) * 2018-02-28 2018-08-14 张晓光 免更换宫内节育器
USD935018S1 (en) * 2020-04-07 2021-11-02 The Population Council, Inc. Contraceptive
EP4215181A1 (en) * 2022-01-21 2023-07-26 Sever Pharma Solutions An intravaginal ring
EP4215180A1 (en) * 2022-01-21 2023-07-26 Sever Pharma Solutions A drug delivery system

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845761A (en) * 1970-06-02 1974-11-05 Alza Corp Intrauterine contraceptive anti-fertility device for the management of reproduction
US3903880A (en) * 1972-08-17 1975-09-09 Alza Corp Intrauterine device for managing the reproductive process
US4069307A (en) 1970-10-01 1978-01-17 Alza Corporation Drug-delivery device comprising certain polymeric materials for controlled release of drug
EG11114A (en) 1973-12-06 1977-01-31 Schering Ag Dispositif contraceptif intra-uterin
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
US4728478A (en) * 1982-08-05 1988-03-01 Allied-Signal Inc. Polymer films containing platelet particles
US4601714A (en) 1983-07-07 1986-07-22 Burnhill Michael S Vaginal device
US5972372A (en) 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
US6821928B2 (en) * 2001-11-06 2004-11-23 Rodney Ruskin Method to reduce the rate of diffusion of slow-release materials through polymers and process for making drip irrigation devices with long-term control of root growth
US20040213846A1 (en) * 2003-04-23 2004-10-28 Greenblatt Gary David Polymer-clay nanocomposite for extended release of active ingredient
US20060251824A1 (en) * 2005-05-05 2006-11-09 Boulais Dennis R Coating of medical devices with solids
WO2009003125A1 (en) * 2007-06-26 2008-12-31 Warner Chilcott Company,Inc. Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs
CA2713943C (en) 2008-02-04 2018-10-23 Teva Women's Health, Inc. Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
KR20140074281A (ko) * 2011-07-20 2014-06-17 패트릭 에프. 카이저 약물 전달용 질내 장치
EP2790637A4 (en) * 2011-12-16 2015-04-29 Combinent Biomedical Systems Inc VAGINAL DRUG DELIVERY DEVICES AND METHODS OF MANUFACTURING THE SAME

Also Published As

Publication number Publication date
EP2953595A1 (en) 2015-12-16
EP2953595B1 (en) 2020-03-11
US11872284B2 (en) 2024-01-16
JP2016508789A (ja) 2016-03-24
US9775905B2 (en) 2017-10-03
HUE049219T2 (hu) 2020-09-28
US20170252444A1 (en) 2017-09-07
WO2014122563A1 (en) 2014-08-14
US20150359890A1 (en) 2015-12-17

Similar Documents

Publication Publication Date Title
ES2787882T3 (es) Un dispositivo intravaginal, y un método para reducir la velocidad de difusión de ingredientes activos en dicho dispositivo intravaginal
JP5380452B2 (ja) ドラッグデリバリーシステム
ES2206865T3 (es) Dispositivo de suministro intravaginal de farmacos.
ES2274367T3 (es) Implante anticonceptivo masculino.
ES3018790T3 (en) Bioerodible drug delivery devices
ES2293193T5 (es) Sistema de suministro retardado con descarga inicial controlada
CA2669833A1 (en) Vaginal delivery system for mirtazapine
ES2388731T3 (es) Dispositivos de administración de fármacos mediante una matriz intravaginal
EP4465958B1 (en) A drug delivery system
ES2365552T3 (es) Sistema de administración vaginal.
JP7692537B2 (ja) 膣内リング
ES2803510T3 (es) Un sistema de administración de fármacos para uno o más principios activos
HK1086751B (en) A longterm delivery system with controlled initial burst